- Home
- SLGL vs FORR Comparison
SLGL vs FORR Comparison
Compare SLGL & FORR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLGL | FORR |
|---|---|---|
| Founded | 1997 | 1983 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.8M | 131.7M |
| IPO Year | 2018 | 1996 |
Fundamental Metrics
Financial Performance| Metric | SLGL | FORR |
|---|---|---|
| Price | $42.02 | $7.40 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $50.00 | N/A |
| AVG Volume (30 Days) | 15.1K | ★ 90.9K |
| Earning Date | 11-20-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $18,970,000.00 | ★ $403,871,000.00 |
| Revenue This Year | $121.82 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 62.04 | N/A |
| 52 Week Low | $4.02 | $6.60 |
| 52 Week High | $52.26 | $16.17 |
Technical Indicators
Market Signals| Indicator | SLGL | FORR |
|---|---|---|
| Relative Strength Index (RSI) | 55.90 | 50.86 |
| Support Level | $39.26 | $7.01 |
| Resistance Level | $44.04 | $7.43 |
| Average True Range (ATR) | 3.07 | 0.25 |
| MACD | -0.03 | 0.10 |
| Stochastic Oscillator | 66.20 | 90.96 |
Price Performance
Historical ComparisonAbout SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
About FORR Forrester Research Inc.
Forrester Research Inc provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.